The question of proteomics' place in the larger world of life science research drove discussion this week at the Human Proteome Organization's 11th annual meeting in Boston as researchers gathered to report on the field's progression and potential as well as the obstacles that continue to limit its adoption by non-experts.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.